Thomas J. DePalma

EngineeringMedicineMaterials ScienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Increasing Accuracy of In Vitro Cancer Models: Engineering Stromal Complexity into Tumor Organoid Platforms”.

Increasing Accuracy of In Vitro Cancer Models: Engineering Stromal Complexity into Tumor Organoid Platforms

Advanced NanoBiomed Research(2021)10.1002/anbr.202100061

N/A

0.416DataRank · unranked

15 citations

Thomas J. DePalma, Aleksander Skardal, Srija Chakraborty

Tuning a bioengineered hydrogel for studying astrocyte reactivity in glioblastoma

Acta Biomaterialia(2024)10.1016/j.actbio.2024.09.048

N/A

0.360DataRank · unranked

10 citations

Colin L. Hisey, Kennedy Hughes, David Fraas, Marie Tawfik, Jason Scharenberg +6 more

Strategies for developing complex multi-component in vitro tumor models: Highlights in glioblastoma

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.114067

N/A

0DataRank · unranked

30 citations

Hemamylammal Sivakumar, Aleksander Skardal, Thomas J. DePalma

Tumor cell-conditioned media drives collagen remodeling via fibroblast and pericyte activation in an in vitro premetastatic niche model

iScience(2022)10.1016/j.isci.2022.104645

N/A

0DataRank · unranked

24 citations

Thomas J. DePalma, Joshua Zent, Jennifer L. Leight, Aleksander Skardal, Kylie G. Nairon

αCT1 peptide sensitizes glioma cells to temozolomide in a glioblastoma organoid platform

Biotechnology and Bioengineering(2022)10.1002/bit.28313

N/A

0DataRank · unranked

21 citations

Thomas J. DePalma, Hemamylammal Sivakumar, Louisa Mezache, Miranda M. Tallman, Monica Venere +4 more